Effect of CagriSema on cardiovascular risk factors and leptin There were no differences between the groups of patients randomized to CagriSema, cagrilintide, and semaglutide in terms of plasma lipid parameters [10]
Blood Vessel Formation: BPC-157 promotes the formation of new blood vessels, which improves nutrient and oxygen delivery to damaged tissues (Wang et al., 2021)
doi:10.1007/s00125-023-05956-x Qureshi N, Wesolowicz L, Stievater T, Lin AT
The cardiovascular evidence is the most solid: in the SELECT trial, people with obesity and established heart disease who added semaglutide cut their risk of cardiovascular death, a second stroke, or a second heart attack by about 20%
Standard clinical recommendation (12 to 24 months) The length of semaglutide treatment for weight loss can differ, but many doctors suggest staying on it for at least 12 to 24 months
Read first, talk to a doctor, or book in whichever stage you're at, there's a no-pressure way in